Katherinne Maria Cortes

Dr. Katherinne Maria Cortes

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
GNGloria Belén Machado Noguera
Gloria Belén Machado Noguera
PQPamela Quimbaya
Pamela Quimbaya
HBHelena Bustos-Cruz
Helena Bustos-Cruz
DJDiego Jaimes
Diego Jaimes
KCKatherinne Maria Cortes
Katherinne Maria Cortes
LPLaura Perdomo
Laura Perdomo
Chronic obstructive pulmonary disease (COPD) is a condition that significantly impacts both patients and healthcare systems. The management of COPD involves various pharmacological intervention strategies, and addressing the issue of low adherence to these strategies has become a subject of significant interest. In response to this concern, there has been a shift toward utilizing telemedicine and mobile applications. The primary objective of this scoping review is to delineate the usage of mobile applications to enhance medication adherence in adult patients with COPD. This study involved a search of databases such as Medline, Google Scholar, Cochrane, and ClinicalTrial.gov, focusing on the literature published in English and Spanish over the last decade. The selected studies assessed interventions involving mobile applications (mobile apps) designed to improve medication adherence. Four digital aids were identified and available on online platforms, mobile apps, or both: m-PAC, myCOPD, Wellinks mHealth, and Propeller Health. Propeller Health, in particular, is an app that directly measures medication adherence through electronic medication monitors attached to participants’ inhalers. Opening the app was associated with higher odds of using control medications compared to participants who did not open the app. The findings suggest that these digital interventions serve as valuable tools to enhance patient adherence to treatment. Future research should focus on evaluating the effectiveness of different digital devices, such as digital inhalers and mobile applications, that directly measure medication adherence.

26 December 2024 in APMIS
Verified
Journal Article
Closed access
MMMarcela Mercado-Reyes
Marcela Mercado-Reyes
DMDaza Marcela
Daza Marcela
RYRodríguez Peña Yazmín
Rodríguez Peña Yazmín
APAraque Muñoz Paula
Araque Muñoz Paula
CFCarlos Franco-Muñoz
Carlos Franco-Muñoz
PÁPiñeros Daza José Ángel
Piñeros Daza José Ángel

1 September 2023
Verified
Preprint
Open access
PDF file
MMMercado-Reyes Marcela
Mercado-Reyes Marcela
DMDaza Marcela
Daza Marcela
RYRodríguez Peña Yazmín
Rodríguez Peña Yazmín
APAraque Muñoz Paula
Araque Muñoz Paula
FCFranco-Muñoz Carlos
Franco-Muñoz Carlos
PÁPiñeros Daza José Ángel
Piñeros Daza José Ángel
Monkeypox (mpox), caused by the MPOXV (monkeypox virus), has been endemic in Africa since its first identification in 1958. However, in May 2022, the world witnessed the first global outbreak associated with the West African clade. Even though thousands of cases have been recorded, our understanding of vertical transmission during pregnancy remains restricted due to an absence of reported cases in pregnant women and a lack of adequate clinical descriptions. The cases of two pregnant women, ages 33 and 24, who tested positive for MPOXV at 31 and 13.4 weeks of gestation, respectively, are presented. In all cases, extensive clinical, histological, and molecular examinations of the mothers and neonates revealed no indication of vertical transmission. Surprisingly, both instances in Colombia were completed without difficulties. Although monkeypox during pregnancy is uncommon, it requires extensive multidisciplinary care.

24 July 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
GNGloria Belén Machado Noguera
Gloria Belén Machado Noguera
PQPamela Quimbaya
Pamela Quimbaya
HBHelena Bustos-Cruz
Helena Bustos-Cruz
DJDiego Jaimes
Diego Jaimes
KCKatherinne Maria Cortes
Katherinne Maria Cortes
LPLaura Perdomo
Laura Perdomo
Chronic obstructive pulmonary disease (COPD) is a condition that significantly impacts both patients and healthcare systems. The management of COPD involves various pharmacological intervention strategies, and addressing the issue of low adherence to these strategies has become a subject of significant interest. In response to this concern, there has been a shift towards utilizing telemedicine and mobile applications. The primary objective of this scoping review is to delineate the usage of mobile applications to enhance pharmacological therapeutic adherence in adult patients with COPD. The study involved a search of databases such as Medline, Google Scholar, Cochrane, and ClinicalTrial.gov, focusing on literature published in English and Spanish over the last decade. The selected studies assessed interventions involving mobile applications (mobile apps) designed to improve pharmacological adherence. Four digital aids were identified, available on online platforms, mobile apps, or both: m-PAC, myCOPD, Wellinks mHealth, and Propeller Health. Pro-peller Health, in particular, is an app that directly measures pharmacological adherence through electronic medication monitors attached to participants' inhalers. Opening the app was associated with higher odds of using control medications compared to participants who did not open the app. The findings suggest that these digital interventions serve as valuable tools to enhance patient adherence to treatment. Future research should focus on evaluating the effectiveness of different digital devices, such as digital inhalers and mobile applications, that directly measure pharmacological adherence.